-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the Provincial Alliance of Oral Implant Systems issued Announcement No.
2, which clarifies that the maximum effective declared price of oral implant product systems is 2380 yuan / set and the agreed purchase volume
in the first year.
Oral implant procurement is scheduled to open on 11 January 2023
.
2, which clarifies that the maximum effective declared price of oral implant product systems is 2380 yuan / set and the agreed purchase volume
in the first year.
Oral implant procurement is scheduled to open on 11 January 2023
.
The collection of products consists of one implant, one repair abutment and one accessory kit, and according to the implant material, it is divided into four pure titanium implant product system and titanium alloy implant product system, a total of two product system categories
.
.
Among them, the procurement demand of the four-grade pure titanium implant product system in the first year was 2494956 sets, and the intended purchase volume in the first year was 2253818 sets; The procurement demand of titanium alloy implant product system in the first year is 375087 sets, and the intended purchase volume in the first year is 339335 sets
.
.
We calculated the approximate purchase amount according to the highest effective declared price and the intended purchase volume in the first year, the purchase amount of grade IV pure titanium implants was about 5.
36 billion yuan, and the purchase amount of titanium alloy implants was about 800 million yuan, the total of the two exceeded 6.
1 billion yuan, far exceeding the market's expectation of implant stock of 3.
1 billion yuan.
36 billion yuan, and the purchase amount of titanium alloy implants was about 800 million yuan, the total of the two exceeded 6.
1 billion yuan, far exceeding the market's expectation of implant stock of 3.
1 billion yuan.
According to the procurement rules, it is divided into two groups, group A is the top 90% of the cumulative purchase volume and meets the supply, and the rest is group
B.
B.
In Group A, the intended purchase amount of each enterprise in the first year is as follows:
In the AB group of four-grade pure titanium implants, Group A is a group with a large procurement volume, a total of 15 enterprises, 11 foreign brands, and the top 9 with the largest procurement volume are foreign brands, Aotootec, Denteng and Strauman occupy the top three in the procurement amount, of which the intended procurement amount of Aotootec and Denteng in the first year exceeds 1 billion yuan
.
.
Among the titanium alloy materials, there are 9 enterprises in Group A, and only 2 domestic enterprises
.
Straumann and Android Health ranked in the top 2, with procurement intentions exceeding 100 million yuan
in the first year.
.
Straumann and Android Health ranked in the top 2, with procurement intentions exceeding 100 million yuan
in the first year.
It can be seen that in the field of oral implants, foreign brands occupy an absolute advantage
.
The collective procurement, whether it is four-grade pure titanium or titanium alloy, the highest effective declared price is 2380 yuan / set, which is much lower than the current market retail price, but the real "limit price" is not this price
.
.
The collective procurement, whether it is four-grade pure titanium or titanium alloy, the highest effective declared price is 2380 yuan / set, which is much lower than the current market retail price, but the real "limit price" is not this price
.
The most noteworthy highlight in Announcement No.
2 is that the benchmark price of each product system is announced, that is, the effective procurement low price, and will be based on the lowest value of the same group as an important indicator, divide the benchmark price by this minimum value to obtain a K value, and then, after the K value is opened to the square root, it will be discounted by 85, which is the "limit price"
required by the quotation.
2 is that the benchmark price of each product system is announced, that is, the effective procurement low price, and will be based on the lowest value of the same group as an important indicator, divide the benchmark price by this minimum value to obtain a K value, and then, after the K value is opened to the square root, it will be discounted by 85, which is the "limit price"
required by the quotation.
Therefore, the benchmark price of each product system (effective procurement low price) and the lowest price in the same group are the most critical price factors, which not only determine the quotation ceiling of the enterprise, but also measure the price level
that can be selected according to the ratio between the respective benchmark price and the lowest price.
that can be selected according to the ratio between the respective benchmark price and the lowest price.
The following table shows the benchmark price of Group A of the four-grade pure titanium implant product system and the lowest price of the same group, note that the lowest price is 742 yuan (Changzhou Baikangte).
The highest price is Straumann, Nobel and Dentsberg three foreign brands, the price is 3373 yuan
.
The highest price is Straumann, Nobel and Dentsberg three foreign brands, the price is 3373 yuan
.
The following table shows the benchmark price of Group B of the four-grade pure titanium implant product system and the lowest price of the same group, the lowest price is 620 yuan, the highest price is 3170 yuan of Tuomei Medical, in addition, the price of Antaike is 2591 yuan, Xike Swiss shares is 2567 yuan, and the price of Yterbium Titanium Technology is 2560 yuan
.
.
The following table shows the benchmark price of each group A/B of the titanium alloy implant product system and the lowest price of the same group, the lowest price of group A is 645 yuan, and the highest price is 3517 yuan of Android Man and Baikang; The lowest price of Group B was 730 yuan, and the highest price was 4005 yuan
for Bangmei 3i.
for Bangmei 3i.
According to the rules of collective procurement, the shortlist is determined first, and then it is necessary to see whether the two conditions for the proposed selection are met
.
.
Shortlisting mainly looks at two conditions, which need to be met
at the same time.
In fact, as analyzed above, this is actually the real "limit price", through each benchmark price and the ratio of the lowest price, to find a lower price level
.
at the same time.
In fact, as analyzed above, this is actually the real "limit price", through each benchmark price and the ratio of the lowest price, to find a lower price level
.
After being shortlisted, the top 60% of the shortlisted price will be taken to directly qualify for Class A; If this rule is not selected, you may also be eligible for the proposed Category B selection by passing one of the following two conditions:
(1) The declared price is not higher than the benchmark price of its own product system× (100%-K×15%)
(2) The declared price is not higher than the benchmark price of its own product system× 55%
It seems that the qualification for Class A is selected from the lowest price, while the qualification for Category B requires manufacturers to give up more price space, and the benchmark price is 55% off, which is unimaginable
.
(If calculated according to the benchmark price of the above tables, the 55% discount of the benchmark price is already lower than the factory price of many manufacturers
.
) ）
.
(If calculated according to the benchmark price of the above tables, the 55% discount of the benchmark price is already lower than the factory price of many manufacturers
.
) ）
Due to its high price, large dosage, high dependence on the import of implants, difficulty in entering medical insurance and many other factors, dental implants have been exploring ways to reduce their prices
from the national level to the local level, adjusting medical insurance limit payment and other methods.
Regarding the centralized procurement of this alliance, Sichuan Medical Insurance Bureau has previously carried out three product information collections
.
from the national level to the local level, adjusting medical insurance limit payment and other methods.
Regarding the centralized procurement of this alliance, Sichuan Medical Insurance Bureau has previously carried out three product information collections
.
It is also worth noting that the centralized procurement of dental implants has not yet started, and relevant regulatory and supervision policies have been introduced
.
In June 2022, nine departments, including the National Health Commission, the Ministry of Public Security, and the State Administration for Market Regulation, issued a notice to correct unhealthy trends in the field of medical purchase and sales and medical services, standardize the charging of dental medical services and consumables, standardize the multi-site practice of dentists in public hospitals, and carry out key inspections
for medical institutions that carry out dental implant services but do not participate in the procurement of dental implant consumables by the Interprovincial Alliance.
.
In June 2022, nine departments, including the National Health Commission, the Ministry of Public Security, and the State Administration for Market Regulation, issued a notice to correct unhealthy trends in the field of medical purchase and sales and medical services, standardize the charging of dental medical services and consumables, standardize the multi-site practice of dentists in public hospitals, and carry out key inspections
for medical institutions that carry out dental implant services but do not participate in the procurement of dental implant consumables by the Interprovincial Alliance.
On September 8, 2022, the National Health Insurance Administration issued the Notice on Carrying out Special Governance of Oral Implant Medical Service Charges and Consumables Prices (No.
2022[27]), which will organize special governance
of oral implant medical service charges and consumables prices.
The whole process of medical service prices for single conventional planting in tertiary public hospitals will be adjusted to 4,500 yuan
.
2022[27]), which will organize special governance
of oral implant medical service charges and consumables prices.
The whole process of medical service prices for single conventional planting in tertiary public hospitals will be adjusted to 4,500 yuan
.
According to public data, the total size of China's dental implant market is about 29.
7 billion yuan, of which the implant market size is 3.
1 billion yuan and 22.
7 billion yuan is the scale
of products and services.
The intended procurement in the first year has exceeded 6 billion yuan, far exceeding the theoretical stock, and it is believed that the quotation will be extremely tragic
.
7 billion yuan, of which the implant market size is 3.
1 billion yuan and 22.
7 billion yuan is the scale
of products and services.
The intended procurement in the first year has exceeded 6 billion yuan, far exceeding the theoretical stock, and it is believed that the quotation will be extremely tragic
.
